Why patient centricity is the answer to the clinical trial enrolment gap
Pharmaceutical Technology
FEBRUARY 13, 2024
Research indicates that designing clinical trials with the patient in mind reduces recruitment times and enhances trial performance.
Sat.Feb 10, 2024 - Fri.Feb 16, 2024
147 
What We Can Learn from Minority Experiences in Clinical Trials
ACRP blog
FEBRUARY 13, 2024
“If we are to improve diversity in clinical trials, we need to understand minority experiences, and how these can be improved to support recruitment and retention,” says Heidi Green, PhD, Director of Health Research Equity, COUCH Health. “The Minority Experiences in Clinical Trials (MERIT) project set out to understanding why ethnic minorities are underrepresented, using a qualitative evidence synthesis to identify factors that influence recruitment.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
What I love About Being a CRA (Clinical Research Associate)
ECRG Media's Clinical Research Podcast
FEBRUARY 14, 2024
What I love About Being a CRA Don't forget to Subscribe for new content! Merch: [link] Subscribe: [link] Email: eliteclinicalgroup@gmail.com Podcast: [link] Steemit: [link] Advertise: eliteclinicalgroup@gmail.com Watch: » Industry News: [link] » All Videos: [link] » Interview Recaps: [link] » Glassdoor Reviews: [link] We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education Elite Clinical Research Group o
February 13, 2024: New Chapter of Living Textbook Highlights Value of Patient Engagement and Provides Practical Strategies
Rethinking Clinical Trials
FEBRUARY 13, 2024
Dr. Steven George The NIH Pragmatic Trials Collaboratory published a new chapter in its Living Textbook of Pragmatic Clinical Trials. The chapter, Patient Engagement , describes principles and strategies for effectively engaging patient partners. Because patients can provide valuable insights and perspectives about clinical care for specific conditions, they are key partners for pragmatic clinical trials.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pfizer and Saama expand deal to expedite clinical research
Pharmaceutical Technology
FEBRUARY 13, 2024
Pfizer has expanded its multi-year agreement with Saama, intensifying efforts to expedite clinical research.
SCOPE: FDA facilitates AI and ML use for clinical trials and drug development
Pharmaceutical Technology
FEBRUARY 13, 2024
Two FDA representatives FDA spoke at the ongoing 2024 SCOPE Summit about how the agency is focusing on AI.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
WCG ClinSphere™: Revolutionizing Clinical Research Technology
WCG Clinical
FEBRUARY 12, 2024
PRINCETON, NJ, February 12, 2024 – WCG, the global leader in providing solutions that measurably improve and accelerate clinical research, announces the upcoming launch of WCG ClinSphere™ , a revolutionary technology platform designed to enable an efficient and optimized clinical research process by leveraging data, insights, and artificial intelligence to connect sites, sponsors, CROs, and participants on a unified, cloud-based system.
February 14, 2024: In This Friday’s PCT Grand Rounds, Clinical Implications of the MINT Trial
Rethinking Clinical Trials
FEBRUARY 14, 2024
Dr. Jeffrey Carson In this Friday’s PCT Grand Rounds, Jeffrey Carson of Rutgers Biomedical and Health Sciences will present “Clinical Implications of the MINT Trial: p=0.07.” The Grand Rounds session will be held on Friday, February 16, 2024, at 1:00 pm eastern. Carson is provost-New Brunswick for Rutgers Biomedical and Health Sciences and the Distinguished Professor of Medicine and Richard C.
MHRA agrees licence change for Pfizer-BioNTech’s Comirnaty vaccine
Pharmaceutical Technology
FEBRUARY 12, 2024
The UK MHRA has granted approval for a variation in licence of Pfizer-BioNTech’s Comirnaty XBB.1.5 vaccine targeting Omicron variant.
Alnylam change to heart drug trial sparks doubts, sinking shares
Bio Pharma Dive
FEBRUARY 15, 2024
Analysts pressed Alnylam executives on the reasons for the changes to HELIOS-B, a Phase 3 study in ATTR amyloidosis with cardiomyopathy that is important to the company’s future.
Obesity Disrupts Mitochondria, And We May Have Figured Out How
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 15, 2024
Scientists have revealed in unprecedented detail how obesity affects mitochondria in mice, causing the cellular powerhouses to fragment into smaller pieces. Mitochondria are famous as “powerhouses of the cell,” given their crucial role in generating energy. Yet the vital work of these organelles is often impaired in people with obesity, for reasons that remain unclear.
Positive results for MAIA’s SCLC treatment published in Nature Communications
Pharma Times
FEBRUARY 14, 2024
The aggressive type of cancer accounts for 13% of all lung cancer cases worldwide
Psychedelic treatments for mental health: Is there substance behind the hype?
Pharmaceutical Technology
FEBRUARY 15, 2024
The success of recent trials treating mental health problems with psychedelic therapies has driven a rapid rise in investment in the area.
Sage offers details on launch of new postpartum depression pill
Bio Pharma Dive
FEBRUARY 14, 2024
The company and partner Biogen say signs from payers and doctors suggest the launch of Zurzuvae, the first oral therapy for PPD, is off to a good start.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Simulations Reveal What Happens When a Sperm Kisses an Egg
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 14, 2024
The moment when a slithering sperm propels itself head-first into a gelatinous egg is one of sudden change. Within seconds to minutes, chemical changes in the egg’s membrane and outer coat are enacted to block any more sperm from attaching to and entering the oocyte.
First UK patients receive experimental mRNA therapy for cancer in global trial
Pharma Times
FEBRUARY 12, 2024
The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359
UK Agency targets blood thinners in personalised medicine pursuit
Pharmaceutical Technology
FEBRUARY 13, 2024
The MHRA kicks off phase two of the Yellow Card biobank to explore the genetic link to side effects of direct oral anticoagulants.
Hunting a non-opioid painkiller, a biotech startup reveals plans to chase Vertex
Bio Pharma Dive
FEBRUARY 14, 2024
Latigo Biotherapeutics has raised $135 million to develop drugs that block NaV1.8, a target shared by a Vertex therapy that just succeeded in Phase 3 testing.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
The Blood of Exceptionally Long-Lived People Reveals Key Differences
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 11, 2024
Centenarians, once considered rare, have become commonplace. Indeed, they are the fastest-growing demographic group of the world’s population, with numbers roughly doubling every ten years since the 1970s. How long humans can live, and what determines a long and healthy life, have been of interest for as long as we know.
Stroke brain-bleed deaths predicted to increase by 40% in the UK
Pharma Times
FEBRUARY 15, 2024
In Europe, stroke-related brain-bleed deaths are expected to increase by 8.
Biotechs ride obesity drug wave with novel approaches that go beyond GLP-1RAs
Pharmaceutical Technology
FEBRUARY 15, 2024
As the market is progressively becoming saturated by GLP-1 receptor agonists, companies are investigating alternative mechanisms of action.
ALS drug from Denali, Sanofi falls short in mid-stage study
Bio Pharma Dive
FEBRUARY 16, 2024
The disclosure the experimental therapy missed its trial goal comes after Sanofi had earmarked the drug for advancement into Phase 3.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
When You Got Your Period May Impact Dementia Risk, Study Finds
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 13, 2024
The ages at which a person starts and stops menstruating could impact their risk of developing dementia later in life, according to the largest study of its kind.
Closed Loop Medicine shares results of proprietary technology for hypertension
Pharma Times
FEBRUARY 15, 2024
CLM-HT01 improved blood pressure and minimised adverse reactions in patients
CRISPR gene therapy Casgevy secures approval in Europe
Pharmaceutical Technology
FEBRUARY 13, 2024
The regulatory greenlight makes it the only gene therapy available in Europe for sickle cell disease and TDT.
Astellas teams up with startup Kelonia to make ‘in vivo’ cell therapies
Bio Pharma Dive
FEBRUARY 16, 2024
Kelonia will receive $40 million upfront through a partnership to develop “off-the-shelf” cell therapies for cancer.
Expiry date for prescription necessary to prevent AMR: AICDF
AuroBlog - Aurous Healthcare Clinical Trials blog
FEBRUARY 14, 2024
The Kolkata headquartered All India Chemists and Distributors Federation (AICDF), a breakaway group of the AIOCD and a body of pharmaceutical distributors and retailers across the country, has informed the government of West Bengal that a period of use or an expiry date, on the lines of the use of therapeutics, is necessary for doctors’ […]
FDA approves Iovance’s Amtagvi as first T-cell therapy for a solid tumor
Fierce Pharma
FEBRUARY 16, 2024
The T-cell therapy treatment class, which has transformed the treatment of certain blood cancers, has now reached the solid tumor field thanks to an FDA approval for a first-of-its-kind immunothera | The T-cell therapy treatment class, which has transformed the treatment of certain blood cancers, has now reached the solid tumor field thanks to an FDA approval for a first-of-its-kind immunotherapy developed by Iovance Biotherapeutics.
FDA approves Eicos’s Aurlumyn for severe frostbite treatment
Pharmaceutical Technology
FEBRUARY 15, 2024
The US FDA has granted approval for Eicos Sciences' Aurlumyn for adults with severe frostbite to lower the risk of amputation.
Chart a course for sustainable growth
Bio Pharma Dive
FEBRUARY 12, 2024
Explore how companies are optimizing efficiency, enhancing customer experiences and embracing AI.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Let's personalize your content